Align Technology Names Kevin Conroy Board Chairman as Longtime Chair Ray Larkin Begins Leadership Transition Align Technology, Inc., the global medical device company best known for its Invisalign clear aligner…
Astrogen Wins International Psychiatry Honor for Autism Clinical Trial Research, Strengthening Momentum for Speragen’s Global Development Astrogen, Inc., a South Korean biotechnology company focused on developing therapies for neurodevelopmental disorders,…
Imperative Care Reports New SYMPHONY-PE Analysis Highlighting Potential Benefits of Early Thrombectomy as Symphony Use Surpasses 500 U.S. Patients Imperative Care, a medical technology company focused on improving treatment options…
bioAffinity Technologies Closes $3.2 Million Public Offering to Support Growth in Lung Disease Diagnostics bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic tools for the early detection…
Walgreens Expands July 4 Pharmacy Access and Holiday Services to Support Independence Day Needs Walgreens is preparing to play an important role for customers this Independence Day by combining holiday…
AngioDynamics Receives FDA Approval to Launch RELIEF Study Evaluating NanoKnife Technology for Benign Prostatic Hyperplasia AngioDynamics, Inc., a medical technology company focused on advancing innovative therapies that improve vascular health,…
Latin Clinical Trial Center Becomes Part of PhaseWell Research, Expanding Research and Therapeutic Access PhaseWell Research, a rapidly growing multisite clinical research organization dedicated to expanding access to clinical trials…
Oligomerix Receives $1.9 Million NIH Grant to Advance Oral Tau-Targeting Therapy for Alzheimer’s Disease Oligomerix, Inc., a privately held clinical-stage biotechnology company focused on developing novel treatments for Alzheimer’s disease…
Gossamer Bio Announces Final Results of Convertible Notes Exchange Offer, Strengthening Financial Position Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on advancing therapies for pulmonary hypertension, has announced the…
Neuron23 Secures $2.5 Million Grant from The Michael J. Fox Foundation to Expand Precision Medicine Parkinson’s Trial into Israel Neuron23 Inc., a clinical-stage biotechnology company focused on advancing precision medicine…
Deciphera Pharmaceuticals Launches Global Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd., has announced a significant milestone in the development…
Jazz Pharmaceuticals and AbCellera Partner to Advance Next-Generation T-Cell Engaging Antibodies for Gastrointestinal and Solid Tumors Jazz Pharmaceuticals and AbCellera have entered into a strategic research collaboration aimed at discovering…